0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

FURTHER EVALUATION OF HYDRALAZINE IN TREATMENT OF HYPERTENSIVE DISEASE

ROBERT D. TAYLOR, M.D.; A. C. CORCORAN, M.D.; HARRIET P. DUSTAN, M.D.; IRVINE H. PAGE, M.D.
AMA Arch Intern Med. 1954;93(5):705-712. doi:10.1001/archinte.1954.00240290063007.
Text Size: A A A
Published online

HYDRALAZINE has come into wide use in treatment of hypertensive disease during the past two years. Opinions as to its usefulness, practicality, and even as to its effectiveness are still widely varied. Thus, we1 found that one-half of a group of patients, many of them with severe disease, responded favorably to its administration over periods of 3 to 12 months; more recently, Hilker, Rhoads, and Billings2 reported a similar incidence of benefit and recommended the drug as a moderately effective antipressor agent useful in office practice. Johnson3 found it an effective hypotensive agent in 65% of his patients treated on an ambulatory basis. However, others* find it of limited value; some use it largely as an adjuvant in association with other antipressor drugs,† and some9 consider it quite ineffective.

In this report we shall describe observations in our previously studied patient group which will demonstrate the effect of 14 further

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();